Despite high prevalence of infectious diseases and substance use disorders in jails, there are limited guidelines for the nursing intake process in this setting. We performed a content analysis of nursing intake forms used at each of the 14 Massachusetts county jails, focusing on infectious disease and substance use disorder. Only 85% of jails offered HIV testing during nursing intake and 50% of jails offered hepatitis C testing. Preventive interventions such as vaccines or pre-exposure prophylaxis therapy were infrequently offered during nursing intake. Screening for substance use disorder was present on the majority of intake forms, but only 23% of intake forms inquired about ongoing medication-assisted treatment for opioid use disorder. The results reflect heterogeneity in nursing intake forms, highlighting missed opportunities for public health interventions.
Get full access to this article
View all access options for this article.
References
1.
AASLD-IDSA HCV Guidance Panel. (2018). Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection. Clinical Infectious Diseases, 67(10),1477–1492. https://doi.org/10.1093/cid/ciy585
2.
Advisory Committee on ImmunizationPractices, FioreA. E., WasleyA., & BellB. P. (2006). Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report. Recommendations and Reports, 55(RR-7),1–23. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5507a1.htm
3.
AlprenC., DawsonE. L., JohnB., CranstonK., PanneerN., FukudaH. D., RooseveltK., KlevensR. M., BryantJ., PetersP. J., LyssS. B., SwitzerW. M., BurrageA., MurrayA., Agnew-BruneC., StilesT., McClungP., CampbellE. M., BreenC., RandallL. M., … BuchaczK. (2020).Opioid use fueling HIV transmission in an urban setting: An outbreak of HIV infection among people who inject drugs—Massachusetts, 2015–2018. American Journal of Public Health, 110(1), 37–44. https://doi.org/10.2105/AJPH.2019.305366
4.
AmmonB., IrohP., TirunehY., LiX., MontagueB. T., RichJ. D., & NijhawanA. E. (2018). HIV care after jail: Low rates of engagement in a vulnerable population. Journal of Urban Health, 95(4),488–498. https://doi.org/10.1007/s11524-018-0231-0
AshfordR. D., BrownA. M., & CurtisB. (2018). Substance use, recovery, and linguistics: The impact of word choice on explicit and implicit bias. Drug and Alcohol Dependence, 189,131–138. https://doi.org/10.1016/j.drugalcdep.2018.05.005
7.
AshfordR. D., BrownA. M., & CurtisB. (2019). “Abusing addiction”: Our language still isn't good enough. Alcohol Treatment Quarterly, 37(2),257–272. https://doi.org/10.1080/07347324.2018.1513777
8.
BassettI. V., FarelC., SzmuilowiczE. D., & WalenskyR. P. (2008). HIV/AIDS: AIDS drug assistance programs in the era of routine HIV testing. Clinical Infectious Diseases, 47(5),695–701. https://doi.org/10.1086/590936
9.
BeckwithC. G., KurthA. E., BazermanL., SolomonL., PatryE., RichJ. D., & KuoI. (2015). Survey of US correctional institutions for routine HCV testing. American Journal of Public Health, 105(1),68–71. https://doi.org/10.2105/AJPH.2014.302071
10.
Brinkley-RubinsteinL., PetersonM., ArnoldT., NunnA. S., BeckwithC. G., CastonguayB., JuniousE., LewisC., & ChanP. A. (2018). Knowledge, interest, and anticipated barriers of pre-exposure prophylaxis uptake and adherence among gay, bisexual, and men who have sex with men who are incarcerated. PLoS One, 13(12), e0205593. https://doi.org/10.1371/journal.pone.0205593
11.
BronsonJ., StroopJ., ZimmerS., & BerzofskyM. (2017). Drug use, dependence, and abuse among state prisoners and jail inmates, 2007–2009 (NCJ 250546). Bureau of Justice Statistics. https://www.bjs.gov/content/pub/pdf/dudaspji0709.pdf
12.
ClarkeJ. G., MartinR. A., GreskoS. A., & RichJ. D. (2018). The first comprehensive program for opioid use disorder in a US statewide correctional system. American Journal of Public Health, 108(10),1323–1325. https://doi.org/10.2105/AJPH.2018.304666
CostumbradoJ., StirlandA., CoxG., El-AminA. N., MirandaA., CarterA., & MalekM. (2012). Implementation of a hepatitis A/B vaccination program using an accelerated schedule among high-risk inmates, Los Angeles County Jail, 2007–2010. Vaccine, 30(48),6878–6882. https://doi.org/10.1016/j.vaccine.2012.09.006
15.
CranstonK., AlprenC., JohnB., DawsonE., RooseveltK., BurrageA., BryantJ., SwitzerW. M., BreenC., PetersP. J., StilesT., MurrayA., FukudaH. D., AdihW., GoldmanL., PanneerN., CallisB., CampbellE. M., RandallL., FranceA. M., … DeMariaA.Jr. (2019). Notes from the field: HIV diagnoses among persons who inject drugs—Northeastern Massachusetts, 2015–2018. Morbidity and Mortality Weekly Report, 68(10),253–254. https://doi.org/10.15585/mmwr.mm6810a6
16.
de la FlorC., PorsaE., & NijhawanA. E. (2017). Opt-out HIV and hepatitis C testing at the Dallas County Jail: Uptake, prevalence, and demographic characteristics of testers. Public Health Reports, 132(6),617–621. https://doi.org/10.1177/0033354917732755
FosterM., RamachandranS., MyattK., DonovanD., BohmS., FiedlerJ., BarbeauB., CollinsJ., ThoroughmanD., McDonaldE., BallardJ., EasonJ., & JorgensenC. (2018). Hepatitis A virus outbreaks associated with drug use and homelessness—California, Kentucky, Michigan, and Utah, 2017. Morbidity and Mortality Weekly Report, 67(43),1208–1210. https://doi.org/10.15585/mmwr.mm6743a3
19.
Francis-GrahamS., EkekeN. A., NelsonC. A., LeeT. Y., HajS. E., RhodesT., VindrolaC., ColbournT., & RosenbergW. (2019). Understanding how, why, for whom, and under what circumstances opt-out blood-borne virus testing programmes work to increase test engagement and uptake within prison: A rapid-realist review. BMC Health Services Research, 19(1), 152. https://doi.org/10.1186/s12913-019-3970-z
HerlihyE. J., KleinS. J., NewcombM. L., BlogD. S., & BirkheadG. S. (2007). Expansion of adult hepatitis A and B vaccination in STD clinics and other settings in New York State. Public Health Reports, 122(2_suppl),36–41. https://doi.org/10.1177/00333549071220S207
22.
KavaseryR., MaruD. S., Cornman-HomonoffJ., SyllaL. N., SmithD., & AlticeF. L. (2009). Routine opt-out HIV testing strategies in a female jail setting: A prospective controlled trial. PLoS One, 4(11), e7648. https://doi.org/10.1371/journal.pone.0007648
23.
KavaseryR., MaruD. S., SyllaL. N., SmithD., & AlticeF. L. (2009). A prospective controlled trial of routine opt-out HIV testing in a men's jail. PLoS One, 4(11), e8056. https://doi.org/10.1371/journal.pone.0008056
24.
KimA. Y., OnofreyS., & ChurchD. R. (2013). An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection. Journal of Infectious Diseases, 207(Suppl 1),S1–S6. https://doi.org/10.1093/infdis/jis927
25.
KishoreS., HaydenM., & RichJ. (2019). Lessons from Scott County—Progress or paralysis on harm reduction? New England Journal of Medicine, 380(21), 1988–1990. https://doi.org/10.1056/NEJMp1901276
26.
LarneyS., KopinskiH., BeckwithC. G., ZallerN. D., JarlaisD. D., HaganH., RichJ. D., van den BerghB. J., & DegenhardtL. (2013). Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta-analysis. Hepatology, 58(4),1215–1224. https://doi.org/10.1002/hep.26387
MacGowanR. J. (2009). HIV testing implementation guidance for correctional settings. Centers for Disease Control and Prevention. https://stacks.cdc.gov/view/cdc/5279
MeyerJ. P., ZelenevA., WickershamJ. A., WilliamsC. T., TeixeiraP. A., & AlticeF. L. (2014). Gender disparities in HIV treatment outcomes following release from jail: Results from a multicenter study. American Journal of Public Health, 104(3),434–441. https://doi.org/10.2105/AJPH.2013.301553
36.
MilloyM. J., KerrT., BuxtonJ., RhodesT., GuillemiS., HoggR., MontanerJ., & WoodE. (2011). Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. Journal of Infectious Diseases, 203(9),1215–1221. https://doi.org/10.1093/infdis/jir032
37.
MontoyJ. C., DowW. H., & KaplanB. C. (2016). Patient choice in opt-in, active choice, and opt-out HIV screening: Randomized clinical trial. BMJ, 532, h6895. https://doi.org/10.1136/bmj.h6895
38.
MorrisM. D., BrownB., & AllenS. A. (2017). Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health. International Journal of Prisoner Health, 13(3–4),192–199. https://doi.org/10.1108/IJPH-07-2016-0028
39.
MurdochD. L., GoaK., & FiggittD. P. (2003). Combined hepatitis A and B vaccines: A review of their immunogenicity and tolerability. Drugs, 63(23),2625–2649. https://doi.org/10.2165/00003495-200363230-00008
40.
National Sheriffs' Association & National Commission on Correctional Health Care. (2018). Jail-based medication-assisted treatment: Promising practices, guidelines, and resources for the field. https://www.sheriffs.org/publications/Jail-Based-MAT-PPG.pdf
41.
NguyenJ. T., RichJ. D., BrockmannB. W., VohrF., SpauldingA., & MontagueB. T. (2015). A budget impact analysis of newly available hepatitis C therapeutics and the financial burden on a state correctional system. Journal of Urban Health, 92(4),635–649. https://doi.org/10.1007/s11524-015-9953-4
42.
NothdurftH. D., DietrichM., ZuckermanJ. N., KnoblochJ., KernP., VollmarJ., & SängerR. (2002). A new accelerated vaccination schedule for rapid protection against hepatitis A and B. Vaccine, 20(7-8),1157–1162. https://doi.org/10.1016/s0264-410x(01)00432-7
43.
PeakC. M., StousS. S., HealyJ. M., HofmeisterM. G., LinY., RamachandranS., FosterM. A., KaoA., & McDonaldE. C. (2020). Homelessness and hepatitis A—San Diego County, 2016–2018. Clinical Infectious Diseases, 71(1),14–21. https://doi.org/10.1093/cid/ciz788
44.
PetersP. J., PontonesP., HooverK. W., PatelM. R., GalangR. R., ShieldsJ., BlosserS. J., SpillerM. W., CombsB., SwitzerW. M., ConradC., GentryJ., KhudyakovY., WaterhouseD., OwenS. M., ChapmanE., RoseberryJ. C., McCantsV., WeidleP. J., BrozD., … Indiana HIV Outbreak InvestigationTeam (2016). HIV infection linked to injection use of oxymorphone in Indiana, 2014–2015. New England Journal of Medicine, 375(3),229–239. https://doi.org/10.1056/NEJMoa1515195
45.
PetersR. H. (1992). Referral and screening for substance abuse treatment in jails. Journal of Mental Health Administration, 19(1),53–75. https://doi.org/10.1007/BF02521308
46.
PetersonM., MacmaduA., TruongA. Q., RichJ., PognonK., LurieM., ClarkeJ. G., & Brinkley-RubinsteinL. (2019). Pre-exposure prophylaxis awareness and interest among participants in a medications for addiction treatment program in a unified jail and prison setting in Rhode Island. Journal of Substance Abuse Treatment, 106,73–78. https://doi.org/10.1016/j.jsat.2019.08.015
PivovarovaE., & SteinM. D. (2019). In their own words: Language preferences of individuals who use heroin. Addiction, 114(10),1785–1790. https://doi.org/10.1111/add.14699
49.
QSR International. (2018). NVivo [qualitative data analysis software]. QSR International Pty Ltd. Version 12.
50.
RosenthalP. (2003). Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adults. Hepatology, 37(1),44–51. https://doi.org/10.1053/jhep.2003.50016
51.
RutledgeR., MaddenL., OgbuaguO., & MeyerJ. P. (2018). HIV risk perception and eligibility for pre-exposure prophylaxis in women involved in the criminal justice system. AIDS Care, 30(10),1282–1289. https://doi.org/10.1080/09540121.2018.1447079
52.
SamoffE., MobleyV., HudginsM., CopeA. B., AdamsN. D., CaputoC. R., DennisA. M., BillockR. M., CrowleyC. A., ClymoreJ. M., & FoustE. (2020). HIV outbreak control with effective access to care and harm reduction in North Carolina, 2017–2018. American Journal of Public Health, 110(3),394–400. https://doi.org/10.2105/AJPH.2019.305490
SmallW., WoodE., BetteridgeG., MontanerJ., & KerrT. (2009). The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: A qualitative study. AIDS Care, 21(6),708–714. https://doi.org/10.1080/09540120802511869
55.
SolomonL., MontagueB. T., BeckwithC. G., BaillargeonJ., CostaM., DumontD., KuoI., KurthA., & RichJ. D. (2014). Survey finds that many prisons and jails have room to improve HIV testing and coordination of postrelease treatment. Health Affairs, 33(3),434–442. https://doi.org/10.1377/hlthaff.2013.1115
56.
SpauldingA. C., AdeeM. G., LawrenceR. T., ChhatwalJ., & von OehsenW. (2018). Five questions concerning managing hepatitis C in the justice system: Finding practical solutions for hepatitis C virus elimination. Infectious Disease Clinics of North America, 32(2),323–345. https://doi.org/10.1016/j.idc.2018.02.014
57.
SpauldingA. C., AndersonE. J., KhanM. A., Taborda-VidarteC. A., & PhillipsJ. A. (2017). HIV and HCV in U.S. prisons and jails: The correctional facility as a bellwether over time for the community's infections. AIDS Reviews, 19(3),134–147.
58.
SpauldingA. C., ChhatwalJ., AdeeM. G., LawrenceR. T., BeckwithC. G., & von OehsenW. (2019). Funding hepatitis C treatment in correctional facilities by using a nominal pricing mechanism. Journal of Correctional Health Care, 25(1),15–24. https://doi.org/10.1177/1078345818805770
59.
SpauldingA. C., SealsR. M., PageM. J., BrzozowskiA. K., RhodesW., & HammettT. M. (2009). HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: Declining share of epidemic but persistent public health opportunity. PLoS One, 4(11), e7558. https://doi.org/10.1371/journal.pone.0007558
60.
StoneJ., FraserH., LimA. G., WalkerJ. G., WardZ., MacGregorL., TrickeyA., AbbottS., StrathdeeS. A., AbramovitzD., MaherL., IversenJ., BruneauJ., ZangG., GarfeinR. S., YenY. F., AzimT., MehtaS. H., MilloyM. J., HellardM. E., … VickermanP. (2018). Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: A systematic review and meta-analysis. The Lancet Infectious Diseases, 18(12),1397–1409. https://doi.org/10.1016/S1473-3099(18)30469-9
61.
U.S. Preventive Services TaskForce, OwensD. K., DavidsonK. W., KristA. H., BarryM. J., CabanaM., CaugheyA. B., DonahueK., DoubeniC. A., EplingJ. W.Jr, KubikM., OgedegbeG., PbertL., SilversteinM., SimonM. A., TsengC. W., & WongJ. B. (2020). Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force recommendation statement. Journal of the American Medical Association 323(10),970–975. DOI: 10.1001/jama.2020.1123.
62.
VongS., FioreA. E., HaightD. O., LiJ., BorgsmillerN., KuhnertW., PineroF., BoazK., BadsgardT., ManciniC., NainanO. V., WiersmaS., & BellB. P. (2005). Vaccination in the county jail as a strategy to reach high risk adults during a community-based hepatitis A outbreak among methamphetamine drug users. Vaccine, 23(8),1021–1028. https://doi.org/10.1016/j.vaccine.2004.07.038
63.
WilsonE., HofmeisterM. G., McBeeS., BriscoeJ., ThomassonE., OlaisenR. H., AugustineR., DuncanE., Bamrah MorrisS., & HaddyL. (2019). Notes from the field: Hepatitis A outbreak associated with drug use and homelessness—West Virginia, 2018. Morbidity and Mortality Weekly Report, 68(14),330–331. https://doi.org/10.15585/mmwr.mm6814a4
64.
WorkowskiK. A., BolanG. A., & Centers for Disease Control andPrevention. (2015). Sexually transmitted diseases treatment guidelines, 2015. Morbidity and Mortality Weekly Report. Recommendations and Reports, 64(RR-03),1–137.
65.
ZallerN., DonadeoK., CoffeyJ., ZielinskiM., & Brinkley-RubinsteinL. (2019). Screening for opioid use disorder in the largest jail in Arkansas: A brief report. Journal of Correctional Health Care, 25(3),214–218. https://doi.org/10.1177/1078345819852133
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
